CRISPR-based diagnostic SHERLOCK has been optimized for rapid use during viral outbreaks by research teams at Broad Institute of MIT and Harvard. The new tool updates SHELOCK which was first unveiled in 2017, to detect pathogens quickly and cheaply directly from body fluids. The study is published in the journal Science.